Does zafirlukast reduce future risk of asthma exacerbations in adults? Systematic review and meta-analysis (Q26863510)

Yan Lv

series ordinal

2

1 reference

Hong Zhang

series ordinal

3

1 reference

Gang Wang

series ordinal

4

1 reference

language of work or name

1 reference

2014

1 reference

Multidisciplinary Respiratory Medicine

published in

1 reference

volume

9

1 reference

issue

1

1 reference

page(s)

30

1 reference

https://scigraph.springernature.com/pub.10.1186/2049-6958-9-30

exact match

0 references

cites work

Diet, occupational exposure and early asthma incidence among bakers, pastry makers and hairdressers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059702

Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059702

The global burden of asthma: executive summary of the GINA Dissemination Committee report

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059702

Asthma control: how it can be best assessed?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059702

New insight into genes in association with asthma: literature-based mining and network centrality analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059702

Genetic polymorphisms and associated susceptibility to asthma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059702

The Asthma Control Test and Asthma Control Questionnaire for assessing asthma control: Systematic review and meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059702

An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059702

A new perspective on concepts of asthma severity and control.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059702

Tolerance and rebound with zafirlukast in patients with persistent asthma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059702

Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059702

Cigarette smoking and asthma: a dangerous mix.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059702

Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent asthma treatment: systematic review of current evidence

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059702

Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059702

Passive smoke exposure impairs recovery after hospitalization for acute asthma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059702

Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059702

Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059702

Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059702

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059702

Insights, attitudes and perceptions about asthma and its treatment: findings from a multinational survey of patients from 8 Asia-Pacific countries and Hong Kong

31 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F2049-6958-9-30

Asthma mortality in the Danish child population: risk factors and causes of asthma death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2049-6958-9-30

Daily versus as-needed corticosteroids for mild persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2049-6958-9-30

Efficacy and safety of low-dose fluticasone propionate compared with zafirlukast in patients with persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2049-6958-9-30

A comparison of short-term treatment with inhaled fluticasone propionate and zafirlukast for patients with persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2049-6958-9-30

Fluticasone propionate versus zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2049-6958-9-30

Effects of zafirlukast upon clinical, physiologic, and inflammatory responses to natural cat allergen exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2049-6958-9-30

The role of LTRAs in the management of persistent asthma

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059702

Zafirlukast improves pulmonary function in patients with moderate persistent asthma receiving regular inhaled steroids: a prospective randomized control study

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059702

Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4059702

Asthma severity, exacerbation risk, and controller treatment burden in underweight and obese children

28 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/24936302

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24936302

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A randomized, double-blind, placebo-controlled trial of the effect of zafirlukast on upper and lower respiratory responses to cat challenge

1 reference

https://pubmed.ncbi.nlm.nih.gov/24936302

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/2049-6958-9-30

1 reference